unguento friezol
pinus indÚstria e comÉrcio ltda. - triclorfon (metrifonato); - ectoparasiticidas (anti-parasitÁrios)
jayempi
nova laboratories ireland limited - azathioprine - rejeição de enxerto - imunossupressores - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
gonazon
intervet international bv - azagly-nafarelin - hormonas e análises pituitárias e hipotalâmicas - dogs; salmonidae (salmonid fish) - feminino salmonídeos peixes como o salmão do atlântico (salmo salar), truta arco-íris (oncorhynchus mykiss), truta (salmo trutta) e arctic charr (salvelinus alpinus)indução e sincronização da ovulação para a produção de eyed-ovos e frite. cães (cadelas)prevenção da função gonadal em cadelas através de longo prazo bloqueio de gonadotrofina síntese.
lymphomyosot
heel do brasil biomÉdica ltda - myosotis arvensis, veronica officinalis, teucrium scorodonia, pinus sylvestris, gentiana lutea, equisetum hyemale, smilax officinalis, scrophularia nodosa, calcium phosphoricum, juglans regia l., natrum sulfuricum, fumaria officinalis l., levothyroxinum, araneus diadematus, geranium robertianum, nasturtium officinale r.br., ferrum iodatum - medicamentos dinamizados compostos
polytar
laboratÓrios stiefel ltda - alcatrÃo do lenho de pinus palustris, alcatrão de pinho, óleo de cade, alcatrÃo mineral, extrato de alcatrão mineral em óleo de aráquide, alcatrÃo de hulha, alcatrÃo do lenho de juniperus oxycedrus - outros produtos com acao na pele e mucosas
maravilha curativa do dr. humphreys
pinus industria quimica e farmaceutica ltda - produtos homeopaticos; fitoterapico simples
lansoprazol aristo 15 mg comprimido orodispersível
aristo pharma gmbh - lansoprazol - comprimido orodispersível - 15 mg - lansoprazol 15 mg - lansoprazole - genérico - duração do tratamento: longa duração
lansoprazol aristo 30 mg comprimido orodispersível
aristo pharma gmbh - lansoprazol - comprimido orodispersível - 30 mg - lansoprazol 30 mg - lansoprazole - genérico - duração do tratamento: longa duração
neluptin 12.5 mg comprimido revestido por película
lupin europe gmbh - tianeptina - comprimido revestido por película - 12.5 mg - tianeptina sódica 12.5 mg - tianeptine - genérico - duração do tratamento: longa duração
neluptin 12.5 mg comprimido revestido por película
lupin europe gmbh - tianeptina - comprimido revestido por película - 12.5 mg - tianeptina sódica 12.5 mg - tianeptine - genérico - duração do tratamento: longa duração